◆个人简历
本人多年来一直从事动物传染病的致病机理与防治研究，主持或参与了国家重点研发项目、863项目、国家科技支撑计划、国家自然科学基金等国家和部省级项目10余项。在动物传染病的防治，尤其在猪病毒性疫病的流行病学、分子致病机制、疫苗研制及疫病综合防控方面取得了一系列进展和创造性研究成果，产生了一定社会经济效益。参与获得国家新兽药注册证书2项、省科技进步二等奖和三等奖各1项、湖北省科技成果鉴定1项，申报国家发明专利40余项，获得发明专利授权20余项。在国内外学术期刊共发表论文100余篇，以第一作者或通讯作者发表论文20余篇，其中SCI收录论文16篇，单篇最高引用达100余次。任World Journal of Virology 和Poultry, Fisheries & Wildlife Sciences杂志编委，Vaccine、African Journal of Biotechnology、Open Veterinary Journal等杂志审稿专家。获得了四川省海外高层次人才、四川省学术与技术带头后备人选、洛阳市优秀科技杰出人才等荣誉称号。参与开发的疫苗产品，已在全国养殖企业广泛应用，产生了较大的经济效益和社会效益，为猪群重要疫病的防控发挥了作用。
◆发表论文
1. Wu R, Wang Q, Liu H, et al. Phylogenetic analysis reveals that Japanese encephalitis virus genotype III is still prevalent in swine herds in Sichuan province in China. Archives of virology 2016 ; 161(6), 1719-1722.
2. Wu R, Wen Y, Huang X, et al. First complete genomic characterization of a porcine parvovirus 5 isolate from China. Archives of virology 2014; 159:1533-1536
3. Rui Wu, Chaoyong Ba, Jinzhong Sun et al. Emergence of virulent pseudorabies virus infection in Northern China. J. Vet. Sci. 2013; 14: 363-365.
4. Rui Wu, Xuke Zhang, Huabin Shao, et al. Characterization of Influenza A Virus With Nine Segments: Effect Gene Segment on Virus Property. Research in Veterinary Science 2012; 93: 1076–80.
5. R. Wu, Z. Liu, W. Liang, et al. Serological and Virological Surveillance of Swine H1N1 and H3N2 Influenza Virus Infection in Two Farms Located in Hubei Province, Central China. Zoonoses and Public Health 2011; 58:508–13.
6. Rui Wu, Yongxiang Tian, Junhua Deng, et al. Multiple amino acid variations in the nonstructural proteins of swine Japanese encephalitis virus alter its virulence in mice. Arch Virol 2011; 156:685–8.
7. Wu R, Guan Y, Yang Z, et al. A live bivalent influenza vaccine based on a H9N2 virus strain. Vaccine 2010; 28(3):673-80.
8. Wu R, Sui Z, Liu Z, et al. Transmission of avian H9N2 influenza viruses in a murine model. Vet Microbiol 2010; 142(3-4):211-6.
9. Wu R, Zhang H, Yang K, et al. Multiple amino acid substitutions are involved in the adaptation of H9N2 avian influenza virus to mice. Vet Microbiol 2009; 138(1-2):85-91.
10.Wu R, Chen Q, Zheng L, Chen et al. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza. Arch Virol 2009; 154(8):1203-10.
11.Wu R, Sui ZW, Zhang HB, et al. Characterization of a pathogenic H9N2 influenza A virus isolated from central China in 2007. Arch Virol 2008; 153(8):1549-55.